Current News

Contact | Print version | Send article | RSS feed

Capsulution Expands its Developmental Facilities
New projects on anti-cancer substances

04 Aug 2006 - In July, Capsulution started to expand its laboratory facilities and thus adapt to the growing customer demand. The aim is to develop Nanotechnology-based delivery systems for cytotoxic substances, like they are employed in modern cancer therapy. Such active compounds require both special laboratory and occupational health and safety conditions. Therefore, a high development quality and safety standard will be secured by a new, separate working area at Capsulution.
 
"The extension of the laboratory technology is a vital key to success for our customers and staff alike and at the same time motivates us to further our product development more effectively under the most modern conditions," states Lutz Kröhne, project director at Capsulution. The handling of highly effective new active components (NCEs) will soon be possible too with the help of our new laboratory technology.